The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Stimulant Treatment Patterns and Compliance in Children and Adults With Newly Treated Attention-Deficit/Hyperactivity Disorder
Open accessAbstract
OBJECTIVE: To identify newly treated cases of attention-deficit/hyperactivity disorder (ADHD), assess the presence of comorbid psychiatric conditions, identify pharmacological treatment patterns, and examine treatment compliance rates among children and adults with newly diagnosed and pharmacologically treated ADHD in a managed care population. METHODS: Children (aged 18 years or younger) and adults having newly treated ADHD were identified from medical and pharmacy claims in an administrative claims database from 6 health plans. Claims data for services or products provided between April 1, 1997, and September 30, 1999, was analyzed for the managed care population (604,538 children and 1,542,304 adults). Data on compliance, persistence, and pharmacological treatment patterns were collected for the 6 months prior to and the 18 months following each patient.s initial ADHD pharmacological treatment. A medication possession ratio (MPR) was calculated by dividing the number of days supplied in a prescription by the number of days until the next prescription was filled. Compliance was defined as an MPR >0.8 and persistence as an MPR >0.3. RESULTS: The prevalence of diagnosed ADHD in this population was 0.7% (11,962 [2%] of children and 2,636 [0.2%] of adults) and incidence of ADHD was 0.04% (735 [0.1%] of children and 162 [0.01%] of adults). The most common comorbid psychiatric condition for incident cases was depression (31.6% of children and 63% of adults). Few children and adults switched their initial ADHD treatment agent, 11% and 12%, respectively. Dose titration occurred in 67% of children and 54% of adults. On average, changes in treatment (switching, titrating) took place after 2 to 3 months of treatment. Although patients, on average, obtained more than 6 refills for a total 200 days supply, the majority of patients (84% of children and 88% of adults) were compliant for less than 2 months over the period they were refilling prescriptions. CONCLUSION: Although the majority of patients had dosage changes, these changes typically occurred after several months of treatment. Results suggest that, even though patients continued their ADHD medication for several months, they did not consistently take medication for more than 2 months. Given these treatment patterns, pharmacologic treatment in newly treated ADHD patients may be suboptimal and may impact outcomes, including the effectiveness and cost of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“most maintain good adherence for fewer than two months (Perwien et al., 2004).”
From The influences of environmental enrichment, cognitive enhancement, and physical exercise on brain development: Can we alter the developmental trajectory of ADHD? (2011) · cites this paper as Perwien et al., 2004
In the citing paper
“estimated adherence rates in children with ADHD only range from 56% to 75%, 16 and more than 50% of patients with ADHD discontinue treatment regardless of its efficacy or symptom severity.17,18”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [18]
In the citing paper
“Despite our high reported adherence rates, our physiological adherence findings are consistent with studies 1, 16,18,29 that have linked poor adherence to adverse outcomes.”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [18]
In the citing paper
“However, unlike some previous studies, we found no associations between adherence and demographic factors such as age, sex, 17,22 family income, and single-parent status 1, 16,18,29,30”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,635
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,627
DSM-III Disorders in Preadolescent Children
Anderson, J. C. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800130081010 · Cited by 1,466
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1792 · Cited by 950
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
Pelham Jr, W. E., Wheeler, T., & Chronis, A. (1998) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2702_6 · Cited by 755
Attention-deficit/hyperactivity disorder in adults: an overview
Faraone, S. V., Biederman, J., Spencer, T. J., Wilens, T., Seidman, L. J., Mick, E. O., & Doyle, A. E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00889-1 · Cited by 703
Attention-Deficit, S. O., & Disorder, H. (2001) · Pediatrics · doi:10.1542/peds.108.4.1033 · Cited by 636
Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment, 2nd ed.
Barkley, R. A. (1998) · Cited by 632
Research works printed but not linked: 2
- MTA Cooperative Group. A 14-month randomized clinical trial of treat- ment strategies for attention-deficit/hyperactivity disorder. Multimodal treat- ment study of children with ADHD. Arch Gen Psychiatry. 1999;56:1073-86.
- Shekin W, Asarnow RF, Hess E, Zaucha K, Wheeler N. A clinical and demographic profile of a sample of adults with ADHD, residual state. Comp Psychiatry. 1990;31(5):416-25.
Cited by
Sorted by citations
Estimating medication persistency using administrative claims data.
Sikka, R., Xia, F., & Aubert, R. E. (2005) · PubMed · Cited by 456
Sonuga‐Barke, E. J. S., & Halperin, J. M. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02195.x · Cited by 320
Review of Medication Adherence in Children and Adults with ADHD
Adler, L. D., & Nierenberg, A. A. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.01.2112 · Cited by 295
Halperin, J. M., & Healey, D. M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.006 · Cited by 237
Sikirica, V., Lü, M., Greven, P., Zhong, Y., Qin, P., Xie, J., & Gajria, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65721 · Cited by 229
Literature Review: ADHD in Adults
Davidson, M. A. (2007) · Journal of Attention Disorders · doi:10.1177/1087054707310878 · Cited by 206
Hoza, B., Smith, A. L., Shoulberg, E. K., Linnea, K. S., Dorsch, T. E., Blazo, J., Alerding, C. M., & McCabe, G. P. (2014) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-014-9929-y · Cited by 178
Preventive Interventions for ADHD: A Neurodevelopmental Perspective
Halperin, J. M., Bedard, A., & Curchack, J. T. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0123-z · Cited by 151
Gau, S. S. F., Shen, H.-Y., Chou, M.-C., Tang, C.-S., Chiu, Y.-N., & Gau, C.-S. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.286 · Cited by 148
Winterstein, A. G., Gerhard, T., Shuster, J. J., ZITO, J. M., Johnson, M. R., Liu, H., & Saidi, A. S. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k143 · Cited by 131
Langberg, J. M., & Becker, S. P. (2012) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-012-0117-8 · Cited by 129
Pappadopulos, E., Jensen, P. S., Chait, A. R., Arnold, L. E., Swanson, J. M., Greenhill, L. L., Hechtman, L., Chuang, S., Wells, K. C., Pelham, W., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23ed · Cited by 112
Halperin, J. M., Marks, D. J., Bedard, A.-C. V., Chacko, A., Curchack, J. T., Yoon, C. A., & Healey, D. M. (2013) · Journal of Attention Disorders · doi:10.1177/1087054711435681 · Cited by 106
Investigating ADHD Treatment Trajectories: Listening to Families' Stories About Medication Use
Leslie, L. K., Plemmons, D. K., Monn, A. R., & Palinkas, L. A. (2007) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3180324d9a · Cited by 100
Berwid, O. G., & Halperin, J. M. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0297-4 · Cited by 113
Stern, L. S., Berman, J., Lumry, W. R., Katz, L. M., Wang, L., Rosenblatt, L. C., & Doyle, J. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60808-3 · Cited by 98
Simulated driving performance of adults with ADHD: comparisons with alcohol intoxication.
Weafer, J., Camarillo, D., Fillmore, M., Milich, R., & Marczinski, C. (2008) · Experimental and clinical psychopharmacology · doi:10.1037/1064-1297.16.3.251 · Cited by 102
Weafer, J., Milich, R., & Fillmore, M. T. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.07.027 · Cited by 92
Hodgkins, P., Sasané, R., & Meijer, W. M. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.03.001 · Cited by 93
Leffa, D. T., Grevet, E. H., Bau, C. H. D., Schneider, M., Ferrazza, C. P., da Silva, R. F., Miranda, M., Picon, F. A., Teche, S. P., Sanches, P., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2055 · Cited by 92
Christensen, L., Sasané, R., Hodgkins, P., Harley, C., & Tetali, S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003673617 · Cited by 86
ADHD medication use, adherence, persistence and cost among Texas Medicaid children
Barner, J. C., Khoza, S., & Oladapo, A. O. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.603303 · Cited by 85
Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients
Gincherman, Y., MOLONEY, K., McKee, C. R., & Coyne, D. W. (2009) · Hemodialysis International · doi:10.1111/j.1542-4758.2009.00397.x · Cited by 78
Halperin, J. M., Berwid, O. G., & O’Neill, S. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.05.005 · Cited by 75
Bussing, R., Zima, B. T., Mason, D. M., Hou, W., GARVAN, C. W., & Forness, S. R. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.78 · Cited by 74
A serious game for children with Attention Deficit Hyperactivity Disorder: Who benefits the most?
Bul, K. C. M., Doove, L. L., Franken, I. H. A., Oord, S. V. D., Kato, P. M., & Maras, A. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193681 · Cited by 71
Barkley, R. A. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1907 · Cited by 71
Fiks, A. G., Mayne, S. L., Hughes, C. C., DeBartolo, E., Behrens, C., Guevara, J. P., & Power, T. J. (2012) · Academic Pediatrics · doi:10.1016/j.acap.2012.04.009 · Cited by 68
Knopf, H. C., Hölling, H., Huß, M., & Schlack, R. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000477 · Cited by 67
Improving Medication Adherence in Chronic Pediatric Health Conditions: A Focus on ADHD in Youth
Chacko, A., H. Newcorn, J., Feirsen, N., & Z. Uderman, J. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791959908 · Cited by 66
Biederman, J., Fried, R. S., DiSalvo, M., Storch, B., Pulli, A., Woodworth, K. Y., Biederman, I., Faraone, S. V., & Perlis, R. H. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800515 · Cited by 69
ADHD Service Use Patterns in Youth
Leslie, L. K., & Wolraich, M. L. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm023 · Cited by 64
Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms
Lam, A. P., Matthies, S., Graf, E., Colla, M., Jacob, C., Sobanski, E., Alm, B., Rösler, M., Retz, W., Retz‐Junginger, P., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.4980 · Cited by 60
Marcus, S. C., & Durkin, M. B. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.02.007 · Cited by 59
Treatment of adult ADHD: Is current knowledge useful to clinicians?
Torgersen, T., Gjervan, B., & Rasmussen, K. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1223 · Cited by 60
Treatment Patterns, Adherence, and Persistence in ADHD: A Canadian Perspective
Lachaîne, J., Beauchemin, C., Sasané, R., & Hodgkins, P. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.05.2557 · Cited by 47
Predictors of Medication Continuity in Children With ADHD
Brinkman, W. B., Sucharew, H., Majcher, J. H., & Epstein, J. N. (2018) · Pediatrics · doi:10.1542/peds.2017-2580 · Cited by 47
Improving psychostimulant adherence in children with ADHD
Charach, A., & Gajaria, A. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.10.1563 · Cited by 46
Muniz, R., Brams, M. N., Mao, A. R., McCague, K., Pestreich, L. K., & Silva, R. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0015 · Cited by 43
Teicher, M. H., Polcari, A. M., & McGreenery, C. E. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0090 · Cited by 42
Hodgkins, P., Sasané, R., Christensen, L., Harley, C., & Liu, F. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.623158 · Cited by 42
Is Physical Activity Causally Associated With Symptoms of Attention-Deficit/Hyperactivity Disorder?
Rommel, A., Lichtenstein, P., Rosenqvist, M. A., Kuja‐Halkola, R., Asherson, P. J., Kuntsi, J., & Larsson, H. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.04.011 · Cited by 42
Lawson, K. A., Johnsrud, M. T., Hodgkins, P., Sasané, R., & Crismon, M. L. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.02.021 · Cited by 43
Stimulant Dosing for Children With ADHD: A Medical Claims Analysis
Olfson, M., Marcus, S., & Wan, G. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31818b1c8f · Cited by 39
Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity
Brinkman, W. B., Baum, R. A., Kelleher, K., Peugh, J., Gardner, W., Lichtenstein, P. K., Langberg, J. M., & Epstein, J. N. (2016) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1016/j.jaac.2016.02.001 · Cited by 34
Persistence of Stimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Palli, S. R., Kamble, P., Chen, H., & Aparasu, R. R. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0028 · Cited by 37
Caisley, H., & Müller, U. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2012.01.002 · Cited by 36
Entry in the ADHD Drugs Market: Welfare Impact of Generics and Me-Toos
Bokhari, F. A. S., & Fournier, G. M. (2011) · Journal of Industrial Economics · doi:10.1111/joie.12017 · Cited by 43
Ferrín, M., Häge, A., Swanson, J. M., Wong, K. H. T. W., Dittmann, R., Banaschewski, T., Coghill, D., Santosh, P., Romanos, M., Simonoff, E. A., et al. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-024-02538-z · Cited by 35
Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD
Brikell, I., Wimberley, T., Albiñana, C., Pedersen, E. M., Vilhjálmsson, B. J., Agerbo, E., Demontis, D., Børglum, A. D., Schork, A. J., LaBianca, S., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20121686 · Cited by 35
Huang, C. L.-C., Chu, C., Cheng, T., & Weng, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095014 · Cited by 34
Quintana, H., Cherlin, E. A., Duesenberg, D. A., Bangs, M. E., Ramsey, J. L., Feldman, P. D., Allen, A. J., & Kelsey, D. K. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.06.017 · Cited by 34
Parents’ Perspectives About Factors Influencing Adherence to Pharmacotherapy for ADHD
Ahmed, R. A., Borst, J., Wei, Y. C., & Aslani, P. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713499231 · Cited by 33
Lensing, M. B., Zeiner, P., Sandvik, L., & Opjordsmoen, S. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07714 · Cited by 32
Biederman, J., Fried, R. S., DiSalvo, M., Woodworth, K. Y., Biederman, I., Driscoll, H., Noyes, E. J., Faraone, S. V., & Perlis, R. H. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05576-y · Cited by 37
Sobanski, E., Retz, W., Fischer, R., Ose, C., Alm, B., Hennig, O., & Rösler, M. (2014) · European psychiatry · doi:10.1016/j.eurpsy.2013.08.004 · Cited by 32
Janssen, L., Kan, C. C., Carpentier, P. J., Sizoo, B. B., Hepark, S., Grutters, J. P. C., Donders, R., Buitelaar, J. K., & Speckens, A. E. M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0591-x · Cited by 35
Kemner, J. E., & Lage, M. J. (2006) · Annals of General Psychiatry · doi:10.1186/1744-859x-5-5 · Cited by 30
Enhanced Physical Activity Improves Selected Outcomes in Children With ADHD
Song, M., Lauseng, D. L., Lee, S., Nordstrom, M., & Katch, V. L. (2016) · Western Journal of Nursing Research · doi:10.1177/0193945916649954 · Cited by 29
Bhang, S., Kwack, Y. S., Joung, Y., Lee, S. I., Kim, B., Sohn, S. H., Chung, U., Yang, J.-W., Hong, M., Bahn, G. H., et al. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.2.158 · Cited by 29
Sikirica, V., Erder, M. H., Xie, J., Macaulay, D. S., Diener, M. D., Hodgkins, P., & Wu, E. Q. (2012) · PharmacoEconomics · doi:10.2165/11632920-000000000-00000 · Cited by 28
Raman, S. R., Marshall, S. W., Gaynes, B. N., Haynes, K., Naftel, A. J., & Stürmer, T. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201300148 · Cited by 28
Pelham, W. E., Smith, B. H., Evans, S. W., Bukstein, O., Gnagy, E. M., Greiner, A. R., & Sibley, M. H. (2017) · Journal of Attention Disorders · doi:10.1177/1087054712474688 · Cited by 27
Youth Views on Communication About ADHD and Medication Adherence
Sleath, B. L., Carpenter, D. M., Sayner, R., Thomas, K. C., Mann, L., Sage, A., Sulzer, S. H., & SANDLER, A. D. (2017) · Community Mental Health Journal · doi:10.1007/s10597-016-0078-3 · Cited by 27
Six-year outcome in subjects diagnosed with attention-deficit/hyperactivity disorder as adults
Edvinsson, D., & Ekselius, L. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0850-6 · Cited by 32
Effect of methylphenidate formulation on treatment patterns and use of emergency room services
Kemner, J. E., & Lage, M. J. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050129 · Cited by 26
Cutler, A. J., Brams, M. N., Bukstein, O. G., Mattingly, G. W., McBurnett, K., White, C., & Rubin, J. S. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.08.001 · Cited by 26
Attention-deficit/hyperactivity disorder in adults: update on clinical presentation and care
Asherson, P. J., Manor, I., & Huß, M. (2014) · Neuropsychiatry · doi:10.2217/npy.14.16 · Cited by 27
Adherence to stimulants in adult ADHD
O’Callaghan, P. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0129-y · Cited by 26
LaFleur, J., Thompson, C. J., Joish, V. N., Charland, S. L., Oderda, G. M., & Brixner, D. I. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g646 · Cited by 23
Khan, M. U., & Aslani, P. (2020) · Health Expectations · doi:10.1111/hex.13031 · Cited by 28
Schein, J. R., Childress, A. C., Adams, J., Cloutier, M., Gagnon‐Sanschagrin, P., Maitland, J., Bungay, R., Guérin, A., & Lefèbvre, P. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1968814 · Cited by 22
Schein, J. R., Childress, A. C., Cloutier, M., Desai, U. S., Chin, A., Simes, M., Guérin, A., & Adams, J. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04016-9 · Cited by 23
Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder
Weisler, R. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.6.745 · Cited by 22
Bruce, C., Unsworth, C. A., Dillon, M. P., Tay, R., Falkmer, T., Bird, P., & Carey, L. M. (2017) · Accident Analysis & Prevention · doi:10.1016/j.aap.2017.10.002 · Cited by 23
Schein, J. R., Childress, A. C., Adams, J., Gagnon‐Sanschagrin, P., Maitland, J., Qu, W., Cloutier, M., & Guérin, A. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04188-4 · Cited by 24
Wu, E. Q., Birnbaum, H. G., Zhang, H. F., Ivanova, J. I., Yang, E. I., & Mallet, D. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.7.561 · Cited by 20
Treuer, T., Feng, Q., Desaiah, D., Altin, M., Wu, S. H., Elshafei, A., Serebryakova, E. A., Gado, M. H., & Faries, D. E. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12437 · Cited by 20
Strategies for improving ADHD medication adherence.
Kamimura-Nishimura, K. I., Brinkman, W. B., & Froehlich, T. E. (2019) · PubMed · Cited by 18
Khan, M., & Aslani, P. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.06.001 · Cited by 17
ADHD Service Use Patterns in Youth
Leslie, L. K., & Wolraich, M. L. (2007) · Ambulatory Pediatrics · doi:10.1016/j.ambp.2006.05.002 · Cited by 18
Hong, M., Lee, W. H., Moon, D. S., Lee, S. M., Chung, U., & Bahn, G. H. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0090 · Cited by 16
Tcheremissine, O. V., & Salazar, J. O. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.8.1299 · Cited by 17
Yang, J.-W., Yoon, B.-M., Lee, M., Joe, S.-H., Jung, I., & Kim, S. (2012) · Psychiatry Investigation · doi:10.4306/pi.2012.9.3.263 · Cited by 16
Risk factors for discontinuing drug therapy among children with ADHD
Bokhari, F. A. S., Heiland, F. W., Levine, P., & Ray, G. (2008) · Health Services & Outcomes Research Methodology · doi:10.1007/s10742-008-0035-x · Cited by 18
Psychopharmacological Treatment of ADHD in Adults Aged 50+: An Empirical Study
Lensing, M. B., Zeiner, P., Sandvik, L., & Opjordsmoen, S. (2015) · Journal of Attention Disorders · doi:10.1177/1087054714527342 · Cited by 18
Warrer, P., Thomsen, P. H., Dalsgaard, S., Hansen, E. H., Aagaard, L., Wallach‐Kildemoes, H., & Rasmussen, H. B. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0060 · Cited by 15
de Farias, A. C., Cordeiro, M. L., Felden, É. P. G., Bara, T. D. S., Benko, C. R., Coutinho, D., Martins, L. F., Chimaleski, R. T., & McCracken, J. T. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s136663 · Cited by 19
Bell, L., Kellison, I. L., GARVAN, C. W., & Bussing, R. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181d5a328 · Cited by 14
Yeh, M., Aarons, G. A., Ho, J., Leslie, L. K., McCabe, K. M., Tsai, K. H., & Hough, R. L. (2013) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-013-0477-5 · Cited by 14
Psychostimulant Prescription for ADHD in New South Wales
Prosser, B. J., Lambert, M. C., & Reid, R. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714553053 · Cited by 14
Braun, S. B., Russo, L., Zeidler, J., Linder, R., & Hodgkins, P. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.03.017 · Cited by 12
Beyond the pill: new medication delivery options for ADHD
Cutler, A. J., & Mattingly, G. W. (2017) · CNS Spectrums · doi:10.1017/s1092852916000936 · Cited by 13
Antony, A. (2016) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.175094 · Cited by 11
Entry in the ADHD Drugs Market: Welfare Impact of Generics and Me-ToosPreprint
Bokhari, F. A. S., & Fournier, G. M. (2011) · SSRN Electronic Journal · doi:10.2139/ssrn.1401546 · Cited by 11
ADHD in children: a path to free medicines
Hayden, J. C., Flood, M., & McNicholas, F. (2015) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-015-1263-z · Cited by 9
Schein, J. R., Cloutier, M., Gauthier‐Loiselle, M., Catillon, M., Meng, Y., Libchaber, B., Jiang, F., & Childress, A. C. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s467724 · Cited by 9
Bhang, S., Hwang, J., Kwak, Y.-S., Joung, Y., Lee, S. I., Kim, B., Sohn, S. H., Chung, U., Yang, J.-W., Hong, M., et al. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.8.1284 · Cited by 9
Bali, V., Kamble, P., & Aparasu, R. R. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.6.486 · Cited by 8
Adherence to medication for attention deficit/hyperactivity disorder: does time frame matter?
Khoza, S., Oladapo, A. O., & Barner, J. C. (2011) · Journal of Pharmaceutical Health Services Research · doi:10.1111/j.1759-8893.2011.00054.x · Cited by 8
Metadata
- Authors
- Perwien, A. R., Hall, J., Swensen, A., & Swindle, R.
- Affiliations
- Eli Lilly (United States) (US)
- ORCID
- Swindle, Ralph
- Venue
- Journal of Managed Care Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2004-03
- Volume
- 10
- Issue
- 2
- Pages
- 122-129
- ISSN
- 1083-4087 (ISSN-L)
- 1944-706X
- PMC
- PMC10437731
- OpenAlex
- W2148237638
- Cited by
- 136
- References
- 30
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 6 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 13
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Managed Care Pharmacy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, medication adherence, treatment persistence, medication possession ratio, comorbid depression, dose titration, treatment switching, managed care, children and adults, prescription refills, psychiatric comorbidity, treatment patterns, pharmacy claims data, health plans
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Female, Humans, Longitudinal Studies, Male, Middle Aged, Patient Compliance, Retrospective Studies, United States, Drug Utilization Review
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review